📰 Iagnostics News
Page 11 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
October 30, 2023
Proposed patient selection process is intended to reduce the cost and improve the safety and efficacy of patient candidate selection for ocular injections...
October 27, 2023
City of Hope, one of the largest cancer research and treatment organizations in the United States, and TGen are leading an international group that has been awarded $4.5 million to validate a liquid biopsy for the early detection of pancreatic cancer.
October 26, 2023
Patients with cancer whose oncologist receives payments from industry appear more likely to receive some non-recommended and low value treatments, finds a US study published by The BMJ today.
October 26, 2023
Psychotherapist Lynn Lyons highlights concerns about the increasing reliance on online ADHD tests by mothers, stressing the need for professional diagnosis.
October 26, 2023
For the first time, people worried about their risk of Alzheimer's disease can go online, order a blood test, and receive results in the privacy of their homes.
October 24, 2023
Artificial intelligence (AI) is already widely used in medical diagnostics. An Austrian-Australian research team led by dermatologist Harald Kittler from MedUni Vienna investigated the extent to which diagnosis and therapy of pigmented skin lesions benefit from it in a realistic clinical scenario.
October 20, 2023
PRESS RELEASE 20 October 2023, 07:00 CEST Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress...
October 20, 2023
Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives. PACE has today (19 October 2023) announced its first funding call with up to £10 million available to support innovators developing new antimicrobials.
October 19, 2023
Researchers have concluded that many people are suffering unnecessarily and that treatment provision offered to patients is failing at many levels.
October 19, 2023
Goldman forecasts a structural decline in volumes to high single digits from the previous estimate of double-digit volume growth. The firm has also said that the valuations of the B2C incumbent are stretched.